Rhythm Pharmaceuticals (RYTM) Assets: 2016-2025
Historic Assets for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to $506.9 million.
- Rhythm Pharmaceuticals' Assets rose 39.42% to $506.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $506.9 million, marking a year-over-year increase of 39.42%. This contributed to the annual value of $392.3 million for FY2024, which is 17.89% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Assets stood at $506.9 million for Q3 2025, which was up 35.99% from $372.7 million recorded in Q2 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Assets peaked at $506.9 million during Q3 2025, and registered a low of $258.7 million during Q1 2024.
- Its 3-year average for Assets is $364.1 million, with a median of $363.6 million in 2024.
- Per our database at Business Quant, Rhythm Pharmaceuticals' Assets skyrocketed by 65.13% in 2021 and then slumped by 32.54% in 2022.
- Rhythm Pharmaceuticals' Assets (Quarterly) stood at $329.5 million in 2021, then increased by 16.07% to $382.5 million in 2022, then decreased by 13.00% to $332.7 million in 2023, then grew by 17.89% to $392.3 million in 2024, then surged by 39.42% to $506.9 million in 2025.
- Its Assets stands at $506.9 million for Q3 2025, versus $372.7 million for Q2 2025 and $386.7 million for Q1 2025.